Droice Labs

RWE from EMR and Patient Data

Real-world evidence is critical for pharma decision making in drug development, payor negotiations, and quantifying unmet patient needs. Each source of real-world patient data has its own format, noise, bias, and nuance and when not combined properly results is low quality, low utility data. Droice Lab’s platform harmonizes patient data from various sources and generates standardized, accurate, and clinically meaningful patient profiles for evidence generation. Trained and tuned on data from millions of patients, Droice’s product has been leveraged by several big pharma companies for evidence generation activities across multiple disease areas including chronic and rare disease.

New York, NY
Mayur Saxena, CEO
Tasha Nagamine, CAIO
Return to Alumni Page

More Alumni Startups